Hereditary Ovarian Cancer and Risk Reduction

Keyphrases

• Risk Reduction 100%
• Breast Cancer Susceptibility Gene 1 (BRCA1) 100%
• RAD51 100%
• BRCA2 100%
• Hereditary Ovarian Cancer 100%
• Next-generation Sequencing 50%
• Mutation Carriers 50%
• Improved Outcomes 50%
• Counseling 50%
• Hormone Replacement Therapy 50%
• Cancer Cases 50%
• High-risk Women 50%
• Variants of Uncertain Significance 50%
• BRIP1 50%
• Epithelial Ovarian Cancer 50%
• Genetic Testing 50%
• Disease Susceptibility 50%
• Occult Malignancy 50%
• Fallopian Tube 50%
• Ovarian Cancer Risk 50%
• Lynch Syndrome 50%
• Fimbriae 50%
• PARP Inhibitor (PARPi) 50%
• Identified Genes 50%
• Ovary Syndrome 50%
• Risk-reducing Salpingo-oophorectomy 50%
• Ovarian Screening 50%
• Hereditary Breast Cancer Syndromes 50%
• High-grade Serous Cancer 50%

Medicine and Dentistry

• Cancer 100%
• Ovarian Cancer 100%
• Risk Reduction 100%
• BRCA1 66%
• BRCA2 66%
• Disease Predisposition 33%
• Hormone Substitution 33%
• Breast Cancer 33%
• Krukenberg Tumor 33%
• Next Generation Sequencing 33%
• Counseling 33%
• Genetic Screening 33%
• Salpingooophorectomy 33%
• Cancer Syndrome 33%
• Hereditary Nonpolyposis Colorectal Cancer 33%
• PARP Inhibitor 33%
• Fimbria 33%
• Fallopian Tube 33%